Healthcare (SH:603313) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-09-08 23:38Core Viewpoint - The company has approved a share repurchase plan to buy back shares for employee stock ownership plans or equity incentives, with a budget between RMB 0.85 billion and RMB 1.70 billion [2] Group 1: Share Repurchase Approval and Plan - The company's board approved the share repurchase plan on May 9, 2025, with a vote of 7 in favor, 0 against, and 0 abstentions [2] - The repurchase will use the company's own funds and special loans, with a maximum repurchase price not exceeding 150% of the average stock price over the previous 30 trading days [2] - The repurchase period is set for up to 12 months from the board's approval date [2] Group 2: Implementation of Share Repurchase - The company initiated its first share repurchase on June 6, 2025, and disclosed the details on June 7, 2025 [3] - As of September 8, 2025, the company had repurchased a total of 19,406,350 shares, representing 3.40% of the total share capital, with a maximum price of RMB 9.139 per share and an average price of RMB 8.588 per share, totaling RMB 166.657095 million [3] Group 3: Execution Consistency and Financial Impact - The actual execution of the repurchase plan aligns with the previously disclosed plan, and the repurchase will not significantly impact the company's normal operations, financial status, or future development [4] - The repurchased shares will be held in a special securities account and will not have voting rights or profit distribution rights during this period [6][7] Group 4: Stock Trading by Related Parties - As of the announcement date, there were no stock trading activities by the company's directors, senior management, controlling shareholders, or actual controllers during the repurchase period [5]